Skip to main content

MoneyWorks4Me

A fair growth of 21.19% in the revenue at Rs. 11799.10 millions was reported in the September 2026 quarter as compared to Rs. 9736.30 millions during year-ago period.An average growth of 31.22% was recorded for the quarter ended September 2026 to Rs. 3346.20  millions from Rs. 2550.00 millions.OP of the company witnessed a marginal growth to 4730.90 millions from 3659.50 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 11799.10 9736.30 21.19 21043.30 17784.60 18.32 37902.00 37234.90 1.79
Other Income 727.70 312.70 132.72 1344.00 750.30 79.13 1425.60 1425.60 0.00
PBIDT 4730.90 3659.50 29.28 8278.80 6604.60 25.35 14427.60 13118.50 9.98
Interest 4.90 5.10 -3.92 14.60 9.30 56.99 27.30 13.10 108.40
PBDT 4726.00 3680.80 28.40 8264.20 6621.70 24.80 14426.70 13152.30 9.69
Depreciation 150.20 174.30 -13.83 308.60 329.50 -6.34 664.40 667.90 -0.52
PBT 4575.80 3506.50 30.49 7955.60 6292.20 26.44 13762.30 12484.40 10.24
TAX 1229.60 956.50 28.55 2076.10 1695.20 22.47 3644.10 3293.80 10.64
Deferred Tax 16.90 4.40 284.09 49.90 4.60 984.78 94.60 62.00 52.58
PAT 3346.20 2550.00 31.22 5879.50 4597.00 27.90 10118.20 9190.60 10.09
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 40.10 37.59 6.68 39.34 37.14 5.94 38.07 35.23 8.04
Peers
Company Name CMP
Sun Pharma. Inds. 1866.95
Dr. Reddys Labs. 1380.00
Cipla 1394.00
Lupin 1972.50
Zydus Lifesciences 1189.00
View more..